Description: Biosergen AB, a biotech company, develops antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Home Page: biosergen.net
Fogdevreten 2
Solna,
171 65
Sweden
Phone:
46 4 52 08 02 470
Officers
| Name | Title |
|---|---|
| Dr. Peder Moller Andersen M.D. | Chief Medical Officer |
| Ms. Tine Kold Olesen Ph.D. | CEO & Member of Executive Board |
| Mr. Niels Laursen M.B.A. | Chief Financial Officer |
| Mr. Sergey B. Zotchev Ph.D. | Chief Scientific Officer and Member of Scientific Advisory Panel |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.6052 |
| Price-to-Sales TTM: | 0.6186 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |